The hottest Hormone Therapy Substack posts right now

Reproductive hormones can have different effects on women, such as premenstrual syndrome and postpartum depression.
Progesterone/progestins in menopausal hormone therapy can impact mood and may have complex interactions in the brain.
Options to consider if progesterone/progestins negatively affect quality of life include switching dosage or trying alternative medications.

Suzanne Somers promoted unsafe compounded hormones as better for menopause under the guise of female empowerment.
Somers popularized the terms 'bioidentical hormones' through media coverage and celebrity endorsement.
Compounded hormones lack safety data and precision dosing compared to pharmaceutical products, making them less safe.

Women with breast cancer may experience genitourinary symptoms due to treatment and menopause.
Various breast cancer medications can lead to severe genitourinary symptoms.
Recent studies offer more insights into the use of vaginal estrogen for women with breast cancer.

Statins are effective for women in reducing cardiovascular disease risk.
Statin side effects are not as common as believed; most often, it's due to the 'nocebo effect'.
Regular ovarian cancer screening methods like ultrasounds and CA-125 tests are not very effective; focus should be on preventive strategies like oral contraception.

Menopausal hormone therapy has both benefits and risks, and it's important for individuals to have accurate information to make informed decisions.
Prioritize exercise, a healthy diet, and not smoking for overall health during menopause.
Menopausal hormone therapy involves prescribing estrogen or progesterone to alleviate symptoms, and progestogen is essential for those taking estrogen to protect against uterine issues.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

Hormone replacement therapy (HRT) can be considered before menopause if a woman is experiencing menopausal symptoms and low estrogen is identified as the cause.
Menopausal hormone therapy (MHT) is generally safe for healthy women when started within 10 years of menopause, and the benefits usually outweigh the risks.
Continuing hormone replacement therapy after the age of 65 should be assessed based on individual health risks and conditions to determine if the benefits still outweigh the potential downsides.

Testosterone therapy for low sexual desire in women is not FDA-approved and is sometimes used off-label. It needs to be approached with caution due to potential risks and lack of long-term safety data.
Low sex drive in a relationship doesn't always need fixing; some couples are content without sexual intimacy. Understanding and respecting each other's needs and choices is important.
It's crucial to consider a variety of potential factors, from hormones to psychological aspects, when addressing low sexual desire. Consulting with a healthcare provider before starting any treatment is essential.

Menopause hormone therapy can be safe and beneficial when prescribed appropriately, considering individual risks and benefits.
Estrogen doesn't cause breast cancer for the majority of women; the benefits of hormone therapy often outweigh the risks.
Women going through menopause should have open conversations with healthcare providers to make informed decisions about hormone therapy.

Lucy McBride is hosting Zoom hangouts for paid subscribers to discuss health topics like Menopause & Women's Health: Risks & Benefits of Hormone Therapy.
The upcoming session focuses on data and decision-making regarding hormone therapy, with an opportunity for subscribers to watch a recording if they can't attend live.
Subscribers can access exclusive content and engage in discussions by subscribing to Lucy McBride's newsletter.